Challenges in Asthma Management: Severity-Based Classification of Patients
Paper Symposium
Activity Date: May 2003  — Activity Info: Volume 3, (5A)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired) | Order Copy of Activity


Full Disclosure Policy Affecting CME Activities:
As a sponsor accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Johns Hopkins University School of Medicine to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Program Director and Participating Faculty reported the following:


    Peter S. Creticos, MD
    Associate Professor of Medicine
    Clinical Director, Division of Allergy and Clinical Immunology
    Johns Hopkins University School of Medicine
    Medical Director, Asthma and Allergy Diseases
    Johns Hopkins Asthma and Allergy Center
    Baltimore, Maryland
    • Dr Creticos reports reports receiving grant and/or research support from, serving as a consultant to, and being a member of the speakers' bureau for ALK; Allergenics; Aradigm; Aventis; AstraZeneca LP; Dynavax; GlaxoSmithKline; Janssen; McNeil; Merck & Co, Inc; Pfizer, Inc; Pharmacia & Upjohn; Schering-Plough; and Stallergenes.


    William J. Calhoun, MD
    Associate Professor of Medicine
    Director, Asthma, Allergy, and Airway Research Center
    Division of Pulmonary, Allergy, and Critical Care Medicine
    University of Pittsburgh
    Pittsburgh, Pennsylvania
    • Dr Calhoun reports receiving grants and/or research support from GlaxoSmithKline; Merck & Co, Inc; and Sepracor, Inc.

    Joseph Spahn, MD
    Associate Professor of Pediatrics
    National Jewish Medical and Research Center
    Denver, Colorado
    • Dr Spahn reports receiving grants and/or research support from GlaxoSmithKline and Merck & Co, Inc; serving as a consultant to AstraZeneca LP and GlaxoSmithKline; and receiving honoraria from AstraZeneca LP, GlaxoSmithKline, and Merck & Co, Inc.

In accordance with the ACCME Standards for Commercial Support, the audience is advised that one or more articles in this continuing medical education activity may contain reference(s) to unlabeled or unapproved uses of drugs or devices. Faculty have indicated that they have not referenced unlabeled/unapproved uses of drugs or products.

Advanced Studies in Medicine provides disclosure information from contributing authors, lead presenters, and participating faculty. Advanced Studies in Medicine does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

Home | Contact Us | View Account | Need Help?